BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: von Stebut E, Boehncke WH, Ghoreschi K, Gori T, Kaya Z, Thaci D, Schäffler A. IL-17A in Psoriasis and Beyond: Cardiovascular and Metabolic Implications. Front Immunol 2019;10:3096. [PMID: 32010143 DOI: 10.3389/fimmu.2019.03096] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 16.0] [Reference Citation Analysis]
Number Citing Articles
1 Karbach S, Hobohm L, Wild J, Münzel T, Gori T, Wegner J, Steinbrink K, Wenzel P, Keller K. Impact of Psoriasis on Mortality Rate and Outcome in Myocardial Infarction. J Am Heart Assoc 2020;9:e016956. [PMID: 32914667 DOI: 10.1161/JAHA.120.016956] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
2 Rackova L, Mach M, Brnoliakova Z. An update in toxicology of ageing. Environ Toxicol Pharmacol 2021;84:103611. [PMID: 33581363 DOI: 10.1016/j.etap.2021.103611] [Reference Citation Analysis]
3 Kothari H, Williams CM, McSkimming C, Drago F, Marshall MA, Garmey J, Vigneshwar M, Zunder ER, McNamara CA. Identification of human immune cell subtypes most responsive to IL-1β-induced inflammatory signaling using mass cytometry. Sci Signal 2021;14:eabc5763. [PMID: 33688079 DOI: 10.1126/scisignal.abc5763] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Ren Y, Bao R, Guo Z, Kai J, Cai CG, Li Z. miR-126-5p regulates H9c2 cell proliferation and apoptosis under hypoxic conditions by targeting IL-17A. Exp Ther Med 2021;21:67. [PMID: 33365067 DOI: 10.3892/etm.2020.9499] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
5 Campanati A, Marani A, Martina E, Diotallevi F, Radi G, Offidani A. Psoriasis as an Immune-Mediated and Inflammatory Systemic Disease: From Pathophysiology to Novel Therapeutic Approaches. Biomedicines 2021;9:1511. [PMID: 34829740 DOI: 10.3390/biomedicines9111511] [Reference Citation Analysis]
6 Queiro R. Cardiometabolic comorbidity in the selection of treatment in spondyloarthritis: one step closer to truly personalized medicine? Expert Opin Biol Ther 2021;21:1539-41. [PMID: 34694176 DOI: 10.1080/14712598.2022.1998448] [Reference Citation Analysis]
7 Wladis EJ, Adam AP. Immune signaling in rosacea. Ocul Surf 2021;22:224-9. [PMID: 34481075 DOI: 10.1016/j.jtos.2021.08.017] [Reference Citation Analysis]
8 Höpfinger A, Karrasch T, Schäffler A, Schmid A. Regulation of CAMP (cathelicidin antimicrobial peptide) expression in adipocytes by TLR 2 and 4. Innate Immun 2021;27:184-91. [PMID: 33509002 DOI: 10.1177/1753425920988167] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Yamanaka-takaichi M, Ghanian S, Katzka DA, Torgerson RR, Alavi A. Candida Infection Associated with Anti-IL-17 Medication: A Systematic Analysis and Review of the Literature. Am J Clin Dermatol. [DOI: 10.1007/s40257-022-00686-z] [Reference Citation Analysis]
10 Heitmann J, Frings VG, Geier A, Goebeler M, Kerstan A. Non-alcoholic fatty liver disease and psoriasis - is there a shared proinflammatory network?J Dtsch Dermatol Ges. 2021;19:517-528. [PMID: 33768700 DOI: 10.1111/ddg.14425] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
11 Szabo TM, Frigy A, Nagy EE. Targeting Mediators of Inflammation in Heart Failure: A Short Synthesis of Experimental and Clinical Results. Int J Mol Sci 2021;22:13053. [PMID: 34884857 DOI: 10.3390/ijms222313053] [Reference Citation Analysis]
12 Wegner J, Karbach S, Drosos I, Schnorbus B, Muxel S, Schmidt F, Wenzel P, Waisman A, Münzel T, Gori T, von Stebut E. TNF-α blockade may lead to improvement of vascular function in psoriasis patients. Exp Dermatol 2021. [PMID: 34432926 DOI: 10.1111/exd.14452] [Reference Citation Analysis]
13 Ohuchi K, Fujimura T, Lyu C, Amagai R, Muto Y, Aiba S. Possible roles of CXCL13/CXCR5 axis in the development of bullous pemphigoid. J Dermatol 2021;48:353-9. [PMID: 33264451 DOI: 10.1111/1346-8138.15713] [Reference Citation Analysis]
14 Graier T, Golob-Schwarzl N, Weger W, Benezeder T, Painsi C, Salmhofer W, Wolf P. Furin Expression in Patients With Psoriasis-A Patient Cohort Endangered to SARS-COV2? Front Med (Lausanne) 2021;8:624462. [PMID: 33644099 DOI: 10.3389/fmed.2021.624462] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Anzai H, Terai T, Wakabayashi-Nakao K, Noguchi T, Kumachi S, Tsuchiya M, Nemoto N. Interleukin-17A Peptide Aptamers with an Unexpected Binding Moiety Selected by cDNA Display under Heterogenous Conditions. ACS Med Chem Lett 2021;12:1427-34. [PMID: 34531951 DOI: 10.1021/acsmedchemlett.1c00217] [Reference Citation Analysis]
16 Heitmann J, Frings VG, Geier A, Goebeler M, Kerstan A. Nicht-alkoholische Fettlebererkrankung und Psoriasis - besteht ein gemeinsames proinflammatorisches Netzwerk? J Dtsch Dermatol Ges 2021;19:517-29. [PMID: 33861000 DOI: 10.1111/ddg.14425_g] [Reference Citation Analysis]
17 Xue K, Shao S, Fang H, Ma L, Li C, Lu Z, Wang G. Adipocyte-Derived CTRP3 Exhibits Anti-Inflammatory Effects via LAMP1-STAT3 Axis in Psoriasis. J Invest Dermatol 2021:S0022-202X(21)02369-1. [PMID: 34687744 DOI: 10.1016/j.jid.2021.09.027] [Reference Citation Analysis]
18 Novelli L, Lubrano E, Venerito V, Perrotta FM, Marando F, Curradi G, Iannone F. Extra-Articular Manifestations and Comorbidities in Psoriatic Disease: A Journey Into the Immunologic Crosstalk. Front Med (Lausanne) 2021;8:737079. [PMID: 34631754 DOI: 10.3389/fmed.2021.737079] [Reference Citation Analysis]
19 Yang J, Lv Y, Zhu Y, Li S, Tao J, Chang L, Zhu M, Zhao J, Wang Y, Wu C, Zhao W. Baseline T-lymphocyte and cytokine indices in sheep peripheral blood. BMC Vet Res 2022;18:165. [PMID: 35513847 DOI: 10.1186/s12917-022-03268-7] [Reference Citation Analysis]
20 Piros ÉA, Szabó Á, Rencz F, Brodszky V, Wikonkál N, Miheller P, Horváth M, Holló P. Anti-Interleukin-17 Therapy of Severe Psoriatic Patients Results in an Improvement of Serum Lipid and Inflammatory Parameters' Levels, but Has No Effect on Body Composition Parameters. Life (Basel) 2021;11:535. [PMID: 34207504 DOI: 10.3390/life11060535] [Reference Citation Analysis]
21 Bonek K, Kuca Warnawin E, Kornatka A, Plebańczyk M, Burakowski T, Maśliński W, Wisłowska M, Głuszko P, Ciechomska M. Circulating miRNA Correlates with Lipid Profile and Disease Activity in Psoriatic Arthritis, Rheumatoid Arthritis, and Ankylosing Spondylitis Patients. Biomedicines 2022;10:893. [DOI: 10.3390/biomedicines10040893] [Reference Citation Analysis]
22 Kukula O, Kırmızıkan S, Tiryaki ES, Çiçekli MN, Günaydın C. Asiatic acid exerts an anti-psoriatic effect in the imiquimod-induced psoriasis model in mice. Immunopharmacol Immunotoxicol 2022;:1-6. [PMID: 35253588 DOI: 10.1080/08923973.2022.2048849] [Reference Citation Analysis]
23 Suarez Carneiro MAM, Silva LDS, Diniz RM, Saminez WFDS, Oliveira PV, Pereira Mendonça JS, Colasso AHM, Soeiro Silva IS, Jandú JJB, Sá JC, Figueiredo CSSES, Correia MTDS, Nascimento da Silva LC. Immunomodulatory and anti-infective effects of Cratylia mollis lectin (Cramoll) in a model of wound infection induced by Staphylococcus aureus. Int Immunopharmacol 2021;100:108094. [PMID: 34508942 DOI: 10.1016/j.intimp.2021.108094] [Reference Citation Analysis]
24 Duncan JW, Nemeth Z, Hildebrandt E, Granger JP, Ryan MJ, Drummond HA. Interleukin-17 induces hypertension but does not impair cerebrovascular function in pregnant rats. Pregnancy Hypertens 2021;24:50-7. [PMID: 33677419 DOI: 10.1016/j.preghy.2021.02.009] [Reference Citation Analysis]
25 Keller K, Hobohm L, Ostad MA, Karbach S, Espinola-Klein C, Münzel T, Gelfand JM, Konstantinides SV, Steinbrink K, Gori T. Psoriasis and its impact on the clinical outcome of patients with pulmonary embolism. Int J Cardiol 2021;343:114-21. [PMID: 34480990 DOI: 10.1016/j.ijcard.2021.08.042] [Reference Citation Analysis]
26 Chen B, Li C, Chang G, Wang H. Dihydroartemisinin targets fibroblast growth factor receptor 1 (FGFR1) to inhibit interleukin 17A (IL-17A)-induced hyperproliferation and inflammation of keratinocytes. Bioengineered 2022;13:1530-40. [PMID: 35006038 DOI: 10.1080/21655979.2021.2021701] [Reference Citation Analysis]
27 Alonso S, Villa I, Fernández S, Martín JL, Charca L, Pino M, Riancho L, Morante I, Santos M, Brandy A, Aurrecoechea E, Carmona L, Queiro R. Multicenter Study of Secukinumab Survival and Safety in Spondyloarthritis and Psoriatic Arthritis: SEcukinumab in Cantabria and ASTURias Study. Front Med (Lausanne) 2021;8:679009. [PMID: 34124110 DOI: 10.3389/fmed.2021.679009] [Reference Citation Analysis]
28 Honma M, Nozaki H. Molecular Pathogenesis of Psoriasis and Biomarkers Reflecting Disease Activity. J Clin Med 2021;10:3199. [PMID: 34361983 DOI: 10.3390/jcm10153199] [Reference Citation Analysis]
29 Orimo K, Tamari M, Saito H, Matsumoto K, Nakae S, Morita H. Characteristics of tissue-resident ILCs and their potential as therapeutic targets in mucosal and skin inflammatory diseases. Allergy 2021. [PMID: 33866593 DOI: 10.1111/all.14863] [Reference Citation Analysis]
30 Yoshida T, Das NA, Carpenter AJ, Izadpanah R, Kumar SA, Gautam S, Bender SB, Siebenlist U, Chandrasekar B. Minocycline reverses IL-17A/TRAF3IP2-mediated p38 MAPK/NF-κB/iNOS/NO-dependent cardiomyocyte contractile depression and death. Cell Signal 2020;73:109690. [PMID: 32553549 DOI: 10.1016/j.cellsig.2020.109690] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
31 Chen Y, Lian P, Peng Z, Wazir J, Ma C, Wei L, Li L, Liu J, Zhao C, Pu W, Wang H, Su Z. Alpha-7 nicotinic acetylcholine receptor agonist alleviates psoriasis-like inflammation through inhibition of the STAT3 and NF-κB signaling pathway. Cell Death Discov 2022;8:141. [PMID: 35351863 DOI: 10.1038/s41420-022-00943-4] [Reference Citation Analysis]
32 Luengas-Martinez A, Hardman-Smart J, Paus R, Young HS. Vascular endothelial growth factor-A as a promising therapeutic target for the management of psoriasis. Exp Dermatol 2020;29:687-98. [PMID: 32654325 DOI: 10.1111/exd.14151] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
33 Piętowska Z, Nowicka D, Szepietowski J. Can Biological Drugs Diminish the Risk of Sarcopenia in Psoriatic Patients? Life 2022;12:435. [DOI: 10.3390/life12030435] [Reference Citation Analysis]
34 Segueni N, Jacobs M, Ryffel B. Innate type 1 immune response, but not IL-17 cells control tuberculosis infection. Biomed J 2021;44:165-71. [PMID: 32798210 DOI: 10.1016/j.bj.2020.06.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
35 Lee HJ, Hong YJ, Kim M. Angiogenesis in Chronic Inflammatory Skin Disorders. Int J Mol Sci 2021;22:12035. [PMID: 34769465 DOI: 10.3390/ijms222112035] [Reference Citation Analysis]
36 Vidal S, Puig L, Carrascosa-Carrillo JM, González-Cantero Á, Ruiz-Carrascosa JC, Velasco-Pastor AM. From Messengers to Receptors in Psoriasis: The Role of IL-17RA in Disease and Treatment. Int J Mol Sci 2021;22:6740. [PMID: 34201664 DOI: 10.3390/ijms22136740] [Reference Citation Analysis]
37 Alves-Filho JC, Marcel Silva Melo B, Ryffel B. MMP-9 Mediates Cross-Talk between Neutrophils and Endothelial Cells in Psoriasis. J Invest Dermatol 2021;141:716-8. [PMID: 33752809 DOI: 10.1016/j.jid.2020.09.006] [Reference Citation Analysis]
38 Banji D, Alqahtani SS, Banji OJF, Machanchery S, Shoaib A. Calming the inflammatory storm in severe COVID-19 infections: Role of biologics- A narrative review. Saudi Pharm J 2021;29:213-22. [PMID: 33850422 DOI: 10.1016/j.jsps.2021.01.005] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
39 Shores LS, Kelly SH, Hainline KM, Suwanpradid J, MacLeod AS, Collier JH. Multifactorial Design of a Supramolecular Peptide Anti-IL-17 Vaccine Toward the Treatment of Psoriasis. Front Immunol 2020;11:1855. [PMID: 32973764 DOI: 10.3389/fimmu.2020.01855] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
40 Blake T, Gullick NJ, Hutchinson CE, Barber TM. Psoriatic disease and body composition: A systematic review and narrative synthesis. PLoS One 2020;15:e0237598. [PMID: 32790787 DOI: 10.1371/journal.pone.0237598] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
41 Anghel F, Nitusca D, Cristodor P. Body Mass Index Influence for the Personalization of the Monoclonal Antibodies Therapy for Psoriasis. Life (Basel) 2021;11:1316. [PMID: 34947847 DOI: 10.3390/life11121316] [Reference Citation Analysis]